In another example of the volatility facing developers of obesity drugs, Veru saw its share price cut nearly in half – despite reporting ostensibly positive data for a drug candidate. Veru's enobosarm ...

It's a piece of exercise "equipment" most people overlook, but that staircase can do more than get you from point A to point B. If you've wondered about the average number of calories burned climbing ...